“Bringing New Hope to Cancer Patients Through Innovation.”
IMGT pursues a singular mission: to expand the boundaries of cancer treatment and offer patients the chance to return to their daily lives.
While conventional chemotherapy has long been the standard of care, its effectiveness has been limited due to restricted drug penetration into tumor tissue.
IMGT’s ChemoSono Therapy technology, which utilizes Focused Ultrasound (FUS), is designed to overcome these barriers. By enhancing drug delivery through ultrasound-induced cavitation, IMGT aims to revolutionize the treatment paradigm for solid tumors.
IMGT will continuously strive to make ChemoSono Therapy a new modality in oncology, providing safer, more effective, and non-invasive treatment options to patients worldwide.
IMGT’s commitment is more than just technology. We are dedicated to restoring hope and improving the quality of life for cancer patients and their families.
Thank you for sharing in IMGT’s vision for a future where cancer no longer dictates life.